OTCMKTS:CAPS

Capstone (CAPS) Stock Price, News & Analysis

$5.20
-1.80 (-25.71%)
(As of 11/28/2023)
Today's Range
$5.00
$5.25
50-Day Range
$5.20
$5.20
52-Week Range
$4.90
$20.00
Volume
300 shs
Average Volume
220 shs
Market Capitalization
$410,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CAPS stock logo

About Capstone Stock (OTCMKTS:CAPS)

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone veneer sidings, hardscapes and related moisture management products, lath products, and fireplaces offered under the Instone and Northeast Masonry names for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC

CAPS Stock Price History

CAPS Stock News Headlines

His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Sabina student helps build underwater robot
See More Headlines
Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2018
Today
4/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CAPS
Employees
52
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
117.41
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Michael M. Toporek (Age 58)
    CEO, President & Chairman
    Comp: $48k
  • Mr. Matthew E. Lipman (Age 45)
    VP, Secretary & Director
    Comp: $48k
  • Edward Schultz
    VP, CFO & Treasurer

CAPS Stock Analysis - Frequently Asked Questions

How have CAPS shares performed in 2024?

Capstone's stock was trading at $5.20 at the start of the year. Since then, CAPS stock has increased by 0.0% and is now trading at $5.20.
View the best growth stocks for 2024 here
.

How were Capstone's earnings last quarter?

Capstone Holding Corp. (OTCMKTS:CAPS) issued its quarterly earnings results on Monday, August, 13th. The biotechnology company reported $0.02 EPS for the quarter. The biotechnology company had revenue of $2 million for the quarter.

What other stocks do shareholders of Capstone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Capstone investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).

How do I buy shares of Capstone?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CAPS) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners